Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 8,004 | 9,043 | 8,576 | 12,423 | 10,643 |
| Cost of Goods | 793 | 1,376 | 1,000 | 1,546 | 1,369 |
| Gross Profit | 7,211 | 7,667 | 7,576 | 10,877 | 9,274 |
| Operating Expenses | 21,956 | 21,116 | 20,754 | 18,174 | 17,355 |
| Operating Income | -13,952 | -13,073 | -13,178 | -6,751 | -7,712 |
| Interest Expense | 0 | 0 | 0 | 11 | 116 |
| Other Income | 2,701 | 2,561 | 2,296 | 1,952 | 1,394 |
| Pre-tax Income | -11,251 | -10,512 | -10,882 | -4,810 | -6,434 |
| Net Income Continuous | -11,251 | -10,512 | -10,882 | -4,810 | -6,434 |
| Net Income | $-11,251 | $-10,512 | $-10,882 | $-4,810 | $-6,434 |
| EPS Basic Total Ops | -0.11 | -0.10 | -0.11 | -0.05 | -0.06 |
| EPS Basic Continuous Ops | -0.11 | -0.10 | -0.11 | -0.05 | -0.06 |
| EPS Diluted Total Ops | -0.11 | -0.10 | -0.11 | -0.05 | -0.06 |
| EPS Diluted Continuous Ops | -0.11 | -0.10 | -0.11 | -0.05 | -0.06 |
| EBITDA(a) | $-14,353 | $-13,958 | $-13,946 | $-7,340 | $-7,921 |